000 | 01107 a2200301 4500 | ||
---|---|---|---|
005 | 20250513211452.0 | ||
264 | 0 | _c20000614 | |
008 | 200006s 0 0 eng d | ||
022 | _a0959-8138 | ||
024 | 7 |
_a10.1136/bmj.320.7246.1354 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aRobinson, N M | |
245 | 0 | 0 |
_aReperfusion in acute myocardial infarction. Ensuring early reperfusion, by whatever means, is the best strategy for now. _h[electronic resource] |
260 |
_bBMJ (Clinical research ed.) _cMay 2000 |
||
300 |
_a1354-5 p. _bdigital |
||
500 | _aPublication Type: Editorial | ||
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aAngioplasty, Balloon, Coronary _xeconomics |
650 | 0 | 4 | _aCost-Benefit Analysis |
650 | 0 | 4 |
_aFibrinolytic Agents _xtherapeutic use |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aMyocardial Infarction _xdrug therapy |
650 | 0 | 4 | _aStents |
650 | 0 | 4 |
_aThrombolytic Therapy _xeconomics |
700 | 1 | _aTimmis, A D | |
773 | 0 |
_tBMJ (Clinical research ed.) _gvol. 320 _gno. 7246 _gp. 1354-5 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1136/bmj.320.7246.1354 _zAvailable from publisher's website |
999 |
_c10769716 _d10769716 |